Henk M.W. Verheul

Researcher Next ID · RN-033648

Researcher · Biochemistry, Genetics and Molecular Biology

Rotterdam, Netherlands

Accepting doctoral researchersFunding unknown

Research interests

Biochemistry, Genetics and Molecular Biology

Medicine

Colorectal Cancer Treatments and Studies

Cancer Immunotherapy and Biomarkers

Cancer Genomics and Diagnostics

Pancreatic and Hepatic Oncology Research

Lung Cancer Treatments and Mutations

γδ T cells are effectors of immunotherapy in cancers with HLA class I defects
Nature · 2023 · https://doi.org/10.1038/s41586-022-05593-1
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
Journal of Clinical Oncology · 2021 · https://doi.org/10.1200/jco.20.03614
Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial
The Lancet Oncology · 2018 · https://doi.org/10.1016/s1470-2045(18)30132-3
RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics
Cancer Cell · 2015 · https://doi.org/10.1016/j.ccell.2015.09.018
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
The Lancet Oncology · 2015 · https://doi.org/10.1016/s1470-2045(15)00040-6
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
New England Journal of Medicine · 2012 · https://doi.org/10.1056/nejmoa1112088
Rapid Decrease in Delivery of Chemotherapy to Tumors after Anti-VEGF Therapy: Implications for Scheduling of Anti-Angiogenic Drugs
Cancer Cell · 2012 · https://doi.org/10.1016/j.ccr.2011.11.023

No projects listed.